News for 'Pfizer'

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

World Cup meets could see spike in COVID in Brazil

World Cup meets could see spike in COVID in Brazil

Rediff.com24 Nov 2022

On World Cup game days, many Brazilians get time off work to pack into bars and restaurants or gather for home barbecues to watch the games, rooting for a national team seeking its sixth world champion title in Qatar.

Mixing COVID-19 vaccines gives good protection: Study

Mixing COVID-19 vaccines gives good protection: Study

Rediff.com29 Jun 2021

According to the study, 'mixed' schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart.

Delta variant now reported in 85 countries: WHO

Delta variant now reported in 85 countries: WHO

Rediff.com24 Jun 2021

The WHO said the four current 'Variants of Concern' being monitored closely - Alpha, Beta, Gamma and Delta - are widespread and have been detected in all WHO regions.

Oxford vaccine set to get UK clearance by year-end

Oxford vaccine set to get UK clearance by year-end

Rediff.com19 Dec 2020

The Medicines and Healthcare Regulatory Agency, which had been formally tasked by the UK government last month with the process of clearance after the jab emerged "safe and effective" against the novel coronavirus in human trials, is expected to authorise the vaccine by December 28 or 29 after the final data is provided on Monday, 'The Daily Telegraph' quoted senior government sources as indicating.

'Everybody's going to get infected'

'Everybody's going to get infected'

Rediff.com27 Dec 2021

'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'

New York nurse first to get Covid vaccine in US

New York nurse first to get Covid vaccine in US

Rediff.com14 Dec 2020

The news comes as the United States approaches 300,000 deaths from COVID-19.

Dom's Take: The race for COVID-19 vaccine

Dom's Take: The race for COVID-19 vaccine

Rediff.com17 Nov 2020

Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.

Production of 1 bn vax doses in India on track: Biden

Production of 1 bn vax doses in India on track: Biden

Rediff.com23 Sep 2021

The Quad partnership is on track to produce at least a billion vaccine doses in India by 2022, US President Joe Biden said on Wednesday, asserting that nothing is more urgent than working together to defeat COVID-19 so the world is much better prepared for future pandemics.

US President Biden gets COVID-19 vaccine booster shot

US President Biden gets COVID-19 vaccine booster shot

Rediff.com28 Sep 2021

Biden got a third Pfizer dose after booster doses were approved by federal health officials.

Oxford vaccine may be first to get nod for emergency use in India

Oxford vaccine may be first to get nod for emergency use in India

Rediff.com26 Dec 2020

Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.

4 more Covid vaccines in pipeline: Health ministry

4 more Covid vaccines in pipeline: Health ministry

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.

90-year-old Maggie world's first to get anti-COVID jab

90-year-old Maggie world's first to get anti-COVID jab

Rediff.com8 Dec 2020

Maggie is among the first set of people contacted in advance by the NHS for the jab based on a pre-determined health risk criteria and will include 87-year-old British Indian grandfather of nine Hari Shukla, who will get his first dose at a hospital in Newcastle.

US sets new record with over 3,000 COVID deaths in 1 day

US sets new record with over 3,000 COVID deaths in 1 day

Rediff.com10 Dec 2020

The previous single-day record was on May 7 at 2,769 deaths.

No decision on granting indemnity to any vaccine producer yet: Govt

No decision on granting indemnity to any vaccine producer yet: Govt

Rediff.com4 Jun 2021

No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government said Friday, underlining these decisions are to be taken 'in the interest of nation and people'.

Sensex hits 43,000-mark for first time; Nifty tops 12,600

Sensex hits 43,000-mark for first time; Nifty tops 12,600

Rediff.com10 Nov 2020

Bajaj Finance was the top gainer in the Sensex pack, surging around 9 per cent, followed by IndusInd Bank, L&T, Bajaj Finserv, HDFC, SBI, ICICI Bank, HDFC Bank, ONGC and Axis Bank. On the other hand, Tech Mahindra, HCL Tech, Infosys, Nestle India, Sun Pharma and TCS closed in the red.

Sputnik vaccine shows 92% efficacy

Sputnik vaccine shows 92% efficacy

Rediff.com27 Nov 2021

'A good 30 per cent of people will still get infected after getting the Covishield vaccine.'

US VP-elect Kamala Harris receives first dose of Moderna COVID-19 vaccine

US VP-elect Kamala Harris receives first dose of Moderna COVID-19 vaccine

Rediff.com30 Dec 2020

The US vice-president-elect received a dose of the Moderna vaccine from clinical nurse Patricia Cummings at United Medical Center, which is located in Southeast Washington, DC.

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Rediff.com2 Mar 2022

Antibodies produced by two doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study that highlights the importance of a booster dose.

Higher Omicron infection risk despite full vax: Study

Higher Omicron infection risk despite full vax: Study

Rediff.com14 Dec 2021

Two doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection.

UK study finds Covid vaccine protection wanes in months

UK study finds Covid vaccine protection wanes in months

Rediff.com25 Aug 2021

The protection gained after being fully vaccinated with both doses of the Pfizer/BioNTech and Oxford/AstraZeneca vaccines against Covid-19 wanes over time, a new UK study reported on Wednesday.

Omicron evades vaccine, antibody therapies: Study

Omicron evades vaccine, antibody therapies: Study

Rediff.com24 Dec 2021

Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today.

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

Serum chief 'hopes to resolve' EU ban on Covishield recipients

Serum chief 'hopes to resolve' EU ban on Covishield recipients

Rediff.com28 Jun 2021

"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.

Serum seeks indemnity from liability; says 'rules should be same for everyone'

Serum seeks indemnity from liability; says 'rules should be same for everyone'

Rediff.com3 Jun 2021

The development comes after requests for indemnity and exemption from bridging trials have been made by Pfizer and Moderna to the Indian government.

87-year-old Indian-origin man first to get COVID-19 vaccine in UK

87-year-old Indian-origin man first to get COVID-19 vaccine in UK

Rediff.com8 Dec 2020

Hari Shukla from Tyne and Wear said he feels it is his duty to receive his first of the two-dose vaccine, a moment UK Prime Minister Boris Johnson hailed as a "huge step forward" as Tuesday was dubbed "V-Day" or Vaccine Day in the UK.

How India Saved More Than 100,000 Lives

How India Saved More Than 100,000 Lives

Rediff.com15 Mar 2023

The vaccination drive was only one important part of India's globally recognised pandemic management and response strategy, observes Dr Vinod K Paul.

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you

Rediff.com13 Apr 2021

The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

Rediff.com10 Dec 2020

Guterres reiterated his call for a COVID-19 vaccine to be a global public good available to everywhere and particularly, available in Africa.

How Serum and Bharat battled for COVID-19 vaccine

How Serum and Bharat battled for COVID-19 vaccine

Rediff.com23 Apr 2021

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.

'Don't deserve this': Bharat Biotech hits outs at critics

'Don't deserve this': Bharat Biotech hits outs at critics

Rediff.com4 Jan 2021

He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".

Over 1 million new COVID-19 cases reported in US

Over 1 million new COVID-19 cases reported in US

Rediff.com4 Jan 2022

The US health authorities registered more than three times as many new cases as in any previous wave of the coronavirus.

What India needs to do to avert China-like Covid surge

What India needs to do to avert China-like Covid surge

Rediff.com28 Dec 2022

"Provide enough infrastructure and money to carry out surveillance and set up a robust routine surveillance machinery for the country to monitor any and every infectious disease'

COVID: 'India is safe for the present'

COVID: 'India is safe for the present'

Rediff.com23 Dec 2022

'Viral infections rise in winter and better care needs to be taken in the next few months.'

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

Rediff.com4 Jan 2021

The Oxford vaccine, which also has a tie-up with the Serum Institute of India, was first administered to Brian Pinker, an 82-year-old Oxford-born dialysis patient. Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the National Health Service (NHS).

Worst days of Covid over, but pandemic will be with us for ever: US official

Worst days of Covid over, but pandemic will be with us for ever: US official

Rediff.com8 Nov 2022

With variants cropping up at regular intervals, Jha acknowledged that they are a concern as a very rapid evolution of this virus is being seen over the time.

Japan denies considering vaccine priority for Olympic athletes

Japan denies considering vaccine priority for Olympic athletes

Rediff.com13 Apr 2021

New infections have spiked ahead of the Olympics, which are set to start in July

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.